Ligne de temps

Julian Buchrieser
Chercheur(euse) Permanent(e)
02 avr. 2024
publication

A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2 spike protein brought to phase I/II clinical trials: candidate selection in a preclinical murine model.

Lire plus
13 mars 2024
publication

Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 lineages combining increased fitness and antibody evasion.

Lire plus
13 déc. 2023
publication

High fusion and cytopathy of SARS-CoV-2 variant B.1.640.1.

Lire plus
25 oct. 2023
publication

TMPRSS2 is a functional receptor for human coronavirus HKU1.

Lire plus
12 mars 2022
publication

Fusogenicity and neutralization sensitivity of the SARS-CoV-2 Delta sublineage AY.4.2.

Lire plus
01 févr. 2022
publication

Considerable escape of SARS-CoV-2 Omicron to antibody neutralization.

Lire plus
26 janv. 2022
publication

Low CCR5 expression protects HIV-specific CD4+ T cells of elite controllers from viral entry.

Lire plus
15 déc. 2021
publication

SARS-CoV-2 Alpha, Beta, and Delta variants display enhanced Spike-mediated syncytia formation.

Lire plus
01 oct. 2021
publication

The Mechanism and Consequences of SARS-CoV-2 Spike-Mediated Fusion and Syncytia Formation.

Lire plus
28 juil. 2021
publication

SUMOylation of SAMHD1 at Lysine 595 is required for HIV-1 restriction in non-cycling cells.

Lire plus
02 juil. 2021
publication

Pregnancy complications and Interferon-induced transmembrane proteins (IFITM): balancing antiviral immunity and placental development.

Lire plus
18 mai 2021
publication

Asymptomatic and symptomatic SARS-CoV-2 infections elicit polyfunctional antibodies.

Lire plus
01 mai 2021
publication

Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies.

Lire plus
25 mars 2021
publication

Quantitative characterization of extracellular vesicle uptake and content delivery within mammalian cells.

Lire plus
01 déc. 2020
publication

Syncytia formation by SARS-CoV-2-infected cells.

Lire plus
01 déc. 2020
publication

Extracellular vesicles containing ACE2 efficiently prevent infection by SARS-CoV-2 Spike protein-containing virus.

Lire plus
02 sept. 2020
publication

A comparison of four serological assays for detecting anti–SARS-CoV-2 antibodies in human serum samples from different populations

Lire plus
05 févr. 2020
publication

Anti-HIV-1 antibodies trigger non-lytic complement deposition on infected cells.

Lire plus
30 janv. 2020
publication

Structure of the prefusion-locking broadly neutralizing antibody RVC20 bound to the rabies virus glycoprotein.

Lire plus
06 déc. 2019
publication

X-ray Structures of the Post-fusion 6-Helix Bundle of the Human Syncytins and their Functional Implications.

Lire plus
18 sept. 2019
publication

Atlastin Endoplasmic Reticulum-Shaping Proteins Facilitate Zika Virus Replication.

Lire plus
12 juil. 2019
publication

IFITM proteins inhibit placental syncytiotrophoblast formation and promote fetal demise.

Lire plus
24 sept. 2018
publication

RIPK1 is a critical modulator of both tonic and TLR-responsive inflammatory and cell death pathways in human macrophage differentiation.

Lire plus
06 juin 2017
publication

A Highly Efficient Human Pluripotent Stem Cell Microglia Model Displays a Neuronal-Co-culture-Specific Expression Profile and Inflammatory Response.

Lire plus
14 févr. 2017
publication

Human Induced Pluripotent Stem Cell-Derived Macrophages Share Ontogeny with MYB-Independent Tissue-Resident Macrophages.

Lire plus
11 mai 2015
team

Virus and Immunity

Lire plus
01 juil. 2011
publication

Identification of a novel neuropathogenic Theiler’s murine encephalomyelitis virus.

Lire plus
04 mai 2011
publication

Identification of a novel neuropathogenic Theiler’s murine encephalomyelitis virus

Lire plus